शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
NIVABUPANSENIVA BUPA HEALTH INS CO L· InsuranceHighNeutral
Announced Wed, 4 Nov, 2026 · 15:24 IST

Standalone quarter ended Sep 2026: insurance revenue up 27%, profit after tax up 124% year on year

Revenue growth above 20%Profit growth above 25%Results restatedResults View source PDFExplain this filing

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+6.8%Reaction day
₹73.06
prior close
₹76.53
announcement price
In-mkt
timing
Nifty Microcap 250market+2.2%+4.6% vs market
General Insurance peers, median of 5sector+1.5%+5.3% vs sector

On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 5.3 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.0
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+6.8+2.2+4.6+1.5+5.3
Next day
+5.3pendingpending+2.8+2.4
2d
+3.8pendingpending+4.0-0.1
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · General Insurance peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone quarter ended Sep 2026 versus Sep 2025: insurance revenue rose 27% to Rs 241,227 lakh and profit after tax rose 124% to Rs 13,564 lakh. Standalone half-year profit after tax: Rs 27,344 lakh versus Rs 13,196 lakh. Auditor review was unmodified. IRDAI barred new locations for six months for exceeding FY2024-25 expense limits. Rs 12,716 lakh tax demands are under appeal. Comparatives were restated under Indian accounting standards.

Likely market impact

Strong revenue and profit growth supports the stock, but the six-month IRDAI expansion restriction and Rs 12,716 lakh tax dispute are key risks.

By the numbers

The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.